GenAI not yet strategic priority with insurers still in early experimentation phase: Oxbow

Despite most specialty insurers and reinsurers seeing generative AI technology as transformational in the longer term, progress is being held back by other strategic objectives, according to an Oxbow Partners report.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com